LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

LLY

1,067.68

+0.83%↑

JNJ

205.97

+1.01%↑

ABBV

229.49

-2.82%↓

UNH

318.47

-0.28%↓

AZN

91.56

+0.6%↑

Search

Nektar Therapeutics

Closed

58.55 8.21

Overview

Share price change

24h

Current

Min

54.11

Max

58.97

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.868

Profit margin

-301.289

Employees

61

EBITDA

6.9M

-29M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+72.92% upside

Market Stats

By TradingEconomics

Market Cap

72M

1.2B

Previous open

50.34

Previous close

58.55

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

24 lis 2025, 21:54 UTC

Acquisitions, Mergers, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24 lis 2025, 18:26 UTC

Major Market Movers

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24 lis 2025, 23:49 UTC

Market Talk

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24 lis 2025, 23:08 UTC

Market Talk

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24 lis 2025, 23:08 UTC

Market Talk

Global Equities Roundup: Market Talk

24 lis 2025, 22:56 UTC

Market Talk
Earnings

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24 lis 2025, 22:47 UTC

Market Talk

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24 lis 2025, 22:36 UTC

Market Talk
Earnings

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24 lis 2025, 22:32 UTC

Earnings

Webco Industries 1Q EPS $6.79 >WEBC

24 lis 2025, 22:07 UTC

Earnings

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24 lis 2025, 22:07 UTC

Earnings

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24 lis 2025, 22:06 UTC

Earnings

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 lis 2025, 22:06 UTC

Earnings

Couche-Tard 2Q Rev $17.9B >ATD.T

24 lis 2025, 22:06 UTC

Earnings

Couche-Tard 2Q EPS 79c >ATD.T

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Rev $17.9B >ATD.T

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Net $740.6M >ATD.T

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 lis 2025, 22:05 UTC

Earnings

Couche-Tard 2Q EPS 79c >ATD.T

24 lis 2025, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

24 lis 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

24 lis 2025, 21:44 UTC

Market Talk

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24 lis 2025, 21:39 UTC

Acquisitions, Mergers, Takeovers

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24 lis 2025, 20:42 UTC

Market Talk

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24 lis 2025, 20:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

24 lis 2025, 19:56 UTC

Acquisitions, Mergers, Takeovers

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24 lis 2025, 18:26 UTC

Market Talk

Crude Futures Move Higher in Choppy Trade -- Market Talk

24 lis 2025, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Basic Materials Roundup: Market Talk

24 lis 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

24 lis 2025, 17:09 UTC

Market Talk

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24 lis 2025, 16:52 UTC

Acquisitions, Mergers, Takeovers

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

72.92% upside

12 Months Forecast

Average 93.86 USD  72.92%

High 120 USD

Low 30 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

6

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat